Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2025-12-25 @ 5:00 AM
NCT ID:
NCT05614518
Eligibility Criteria:
1. Male or female, age 18 to 75 years, inclusive.
2. It is confirmed to be lung cancer, prostate cancer or breast cancer by combining medical history, imaging and pathological examination, and radionuclide bone imaging is required, and any one of the following is required:
1. Bone imaging within 3 months before the signing the ICF cannot exclude bone metastasis.
2. Associated with clinical manifestations related to bone metastasis, including bone pain, activity disorder, pathological fracture, spinal cord or spinal nerve compression symptoms, alkaline phosphatase elevation, hypercalcemia or Prostate Specific Antigen (PSA) \>10 ng / ml.
3. Those with definite metastasis outside the primary tumor focus.
4. Patients with a history of bone metastasis.
5. Patients who need to confirm the status of bone metastasis for tumor staging.
3. According to the standard of the Eastern Cooperative Oncology Group (ECOG), the score was 0-1.
4. The expected survival of the Patients was \> 6 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05614518
Study Brief:
Protocol Section:
NCT05614518